Internet-based Program for Prevention and Early Intervention of Adolescent Depression

September 25, 2019 updated by: Vania Martínez-Nahuel, University of Chile

Efficacy of a Stepped Internet-based Program for Prevention and Early Intervention of Depression in Adolescents

Background: Depression is prevalent and can have devastating effects on the life of adolescents. Computerized intervention programs for depression have shown positive results. There is less evidence in prevention and early treatment for depression in Latin American adolescents.

Purpose: The purpose of this study is to determine whether a stepped internet-based program is effective to prevent and early intervene depression in adolescents attending 9th to 11th grade in eight schools in Santiago, Chile.

Study design: A two-arm cluster-randomized clinical trial will be carried out with approximately 600 adolescents.

Study Overview

Study Type

Interventional

Enrollment (Actual)

947

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Region Metropolitana
      • Santiago, Region Metropolitana, Chile, 8380455
        • CEMERA, Faculty of Medicine, Universidad de Chile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 15 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Attending from ninth grade to eleventh grade in the eight participating schools.
  • Informed consent and informed assent.
  • Score in the depression questionnaire PHQ-9 adolescent version between 5 and 14.

Exclusion Criteria:

  • High suicide risk defined by score in question 9 of the PHQ-9 adolescent version of 2 or more.
  • Current treatment with antidepressant drugs.
  • Current treatment with psychotherapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group

The intervention consists of an Internet-based program. The program will last 3 months, with subsequent monthly reinforcement sessions for other 3 months.

The program is stepped, so that the more depressive symptomatology the more intensive program and consists of more components.

The students will interact with the program via a monitoring and feedback e-mail with 3 questions of the PHQ--9- adolescent version (1st, 2nd & 9th question) that they will receive every 2 weeks and a Website that will allow them to access to psycho-educational videos and information. There will also in the Website sections that will provide emergency information, the possibility of a contact via e-mail, and group chats. Adolescents with more depressive symptoms or suicidal risk will be invited to participate in an online counselling appointment or a face to face assessment with a mental health professional of the program.

The adolescents will be registered in the Website www.cuidatuanimo.org
Other: Control group
The comparison group will receive general psychoeducation of depression in adolescents and will be on the waiting list to receive the intervention in the event that its efficacy is demonstrated.
The adolescents will visit the Website www.cuidatuanimo.org, but they can not register

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive Symptoms
Time Frame: 6 months after baseline assessment
Patient Health Questionnaire-9 (PHQ-9) adolescent version, total score varies between 0 and 27, higher values represent a worse outcome
6 months after baseline assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive Symptoms
Time Frame: 12 months after baseline assessment
Patient Health Questionnaire-9 (PHQ-9) adolescent version, total score varies between 0 and 27, higher values represent a worse outcome
12 months after baseline assessment
Anxiety Symptoms
Time Frame: 6 and 12 months after baseline assessment
Generalized Anxiety Disorder-7 (GAD-7) adolescent version, total score varies between 0 and 21, higher values represent a worse outcome
6 and 12 months after baseline assessment
Health-Related Quality of Life Index
Time Frame: 6 and 12 months after baseline assessment
KIDSCREEN-10 index, total score varies between -3.53 and 83.8, higher values represent a better outcome
6 and 12 months after baseline assessment
Social Problem Solving Skills
Time Frame: 6 and 12 months after baseline assessment
Social Problem Solving Inventory-Revised Short Form (SPSI-RS), positive problem subscale orientation, and rational problem solving subscale, total score of each subscale varies between 0 to 20, higher scores represent better outcome
6 and 12 months after baseline assessment
Dysfunctional Thoughts
Time Frame: 6 and 12 months after baseline assessment
Children's Automatic Thought Questionnaire (CATS), personal failure subscale, total score of the subscale varies between 0 and 40, higher values represent worse outcome
6 and 12 months after baseline assessment
Emotion Regulation
Time Frame: 6 and 12 months after baseline assessment
Emotion Regulation Questionnaire (ERQ), reappraisal subscale, total score of the subscale varies between 6 and 42, higher values represent better outcome
6 and 12 months after baseline assessment
Depression Stigma
Time Frame: 6 and 12 months after baseline assessment
Depression Stigma Scale (DSS), personal stigma subscale, total score of the subscale varies between 0 and 36, higher values represent worse outcome
6 and 12 months after baseline assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vania Martinez, PhD, University of Chile

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 18, 2018

Primary Completion (Actual)

May 31, 2019

Study Completion (Actual)

August 31, 2019

Study Registration Dates

First Submitted

April 17, 2018

First Submitted That Met QC Criteria

April 27, 2018

First Posted (Actual)

May 11, 2018

Study Record Updates

Last Update Posted (Actual)

September 27, 2019

Last Update Submitted That Met QC Criteria

September 25, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FONDECYT 1161696

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe